7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Valvular Atrial Fibrillation
Valvular Atrial Fibrillation (VAF) is a distinct category of atrial fibrillation that manifests in individuals with significant heart valve disorders. The abnormal electrical signals within the atria, or upper chambers of the heart, lead to irregular and often accelerated heartbeats. The link between VAF and valvular heart diseases, such as mitral stenosis or the presence of a mechanical heart valve, underscores the complexity of this condition. The management of VAF requires a nuanced approach, taking into account both the atrial fibrillation and the underlying valvular pathology. Healthcare professionals navigate treatment strategies based on factors like the severity of the valve disease, the overall health status of the patient, and individual considerations unique to each case. Striking a balance between addressing atrial fibrillation and managing valvular issues is crucial for effective care.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Steve Cohen
Medvesta Hypnosis Healthcare, NSA Illinois, United States
Ruth Rasmussen
Liberty University, United States
Franz Porzsolt
Private Research Institute Clinical Economics, GermanySubmit your abstract Today
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Implantation of permanent cardiac pacemakers with right-sided access in collaboration with a vascular surgeon: pro et contra
Davor Horvat, General Hospital, , Croatia (Hrvatska)
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Panpan Hao, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, Shandong, China